| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-13 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |